Sulodexide Completed Phase 2 Trials for Tinnitus, Subjective Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02737670Sulodexide Efficacy in Chronic Idiopathic Subjective Tinnitus